{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:55:47Z","timestamp":1787774147427,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41371-021-00525-4","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T10:03:17Z","timestamp":1617098597000},"page":"373-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aldosterone-producing adenoma associated with non-suppressed renin: a case series"],"prefix":"10.1038","volume":"36","author":[{"given":"Pieter Martijn","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-8584","authenticated-orcid":false,"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"525_CR1","first-page":"220","volume":"66","author":"PM Jansen","year":"2008","unstructured":"Jansen PM, Boomsma F, van den Meiracker AH, Dutch AI. Aldosterone-to-renin ratio as a screening test for primary aldosteronism-the Dutch ARRAT Study. Neth J Med. 2008;66:220\u20138.","journal-title":"Neth J Med."},{"key":"525_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045\u201350.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"525_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","volume":"22","author":"NM Kaplan","year":"2004","unstructured":"Kaplan NM. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens. 2004;22:863\u20139.","journal-title":"J Hypertens."},{"key":"525_CR5","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40:897\u2013902.","journal-title":"Hypertension."},{"key":"525_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1210\/jc.2010-2603","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"Ahmed AH, Calvird M, Gordon RD, Taylor PJ, Ward G, Pimenta E, et al. Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone\/renin ratio in normotensive depressed male patients. J Clin Endocrinol Metab. 2011;96:1039\u201345.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/jc.2004-1149","volume":"90","author":"SC Tiu","year":"2005","unstructured":"Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab. 2005;90:72\u20138.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ajh\/1.4.353","volume":"1","author":"M Volpe","year":"1988","unstructured":"Volpe M, Lembo G, Morganti A, Condorelli M, Trimarco B. Contribution of the renin-angiotensin system and of the sympathetic nervous system to blood pressure homeostasis during chronic restriction of sodium intake. Am J Hypertens. 1988;1:353\u20138.","journal-title":"Am J Hypertens."},{"key":"525_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","volume":"32","author":"PM Jansen","year":"2014","unstructured":"Jansen PM, van den Born BJ, Frenkel WJ, de Bruijne EL, Deinum J, Kerstens MN, et al. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism. J Hypertens. 2014;32:115\u201326.","journal-title":"J Hypertens."},{"key":"525_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","volume":"76","author":"VM Montori","year":"2001","unstructured":"Montori VM, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc. 2001;76:877\u201382.","journal-title":"Mayo Clin Proc."},{"key":"525_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0002-9343(83)91022-7","volume":"74","author":"EL Bravo","year":"1983","unstructured":"Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW, et al. The changing clinical spectrum of primary aldosteronism. Am J Med. 1983;74:641\u201351.","journal-title":"Am J Med."},{"key":"525_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.jhh.1000444","volume":"11","author":"H Ignatowska-Switalska","year":"1997","unstructured":"Ignatowska-Switalska H, Chodakowska J, Januszewicz W, Feltynowski T, Adamczyk M, Lewandowski J. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism. J Hum Hypertens. 1997;11:373\u20138.","journal-title":"J Hum Hypertens"},{"key":"525_CR13","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1210\/jc.2016-3821","volume":"102","author":"AH Ahmed","year":"2017","unstructured":"Ahmed AH, Gordon RD, Ward G, Wolley M, McWhinney BC, Ungerer JP, et al. Effect of moxonidine on the aldosterone\/renin ratio in healthy male volunteers. J Clin Endocrinol Metab. 2017;102:2039\u201343.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR14","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2018-01394","volume":"103","author":"M Stowasser","year":"2018","unstructured":"Stowasser M, Ahmed AH, Cowley D, Wolley M, Guo Z, McWhinney BC, et al. Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2018;103:4113\u201324.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR15","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","volume":"34","author":"J Burrello","year":"2016","unstructured":"Burrello J, Monticone S, Buffolo F, Lucchiari M, Tetti M, Rabbia F, et al. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism. J Hypertens. 2016;34:920\u20137.","journal-title":"J Hypertens."},{"key":"525_CR16","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38:1919\u201328.","journal-title":"J Hypertens"},{"key":"525_CR17","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1210\/jc.2018-01041","volume":"103","author":"Z Guo","year":"2018","unstructured":"Guo Z, Poglitsch M, McWhinney BC, Ungerer JPJ, Ahmed AH, Gordon RD, et al. Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. J Clin Endocrinol Metab. 2018;103:3965\u201373.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/archinte.1970.00310100067006","volume":"126","author":"T Saruta","year":"1970","unstructured":"Saruta T, Saade GA, Kaplan NM. A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release. Arch Intern Med. 1970;126:621\u20136.","journal-title":"Arch Intern Med"},{"key":"525_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","volume":"31","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281\u2013357. 2013","journal-title":"J Hypertens"},{"key":"525_CR20","first-page":"540","volume":"19","author":"M Tanemoto","year":"2006","unstructured":"Tanemoto M, Honkura K, Abe M, Satoh F, Abe T, Ito S. Aldosterone-producing adenoma accompanied with renal artery stenosis. J Nephrol. 2006;19:540\u20132.","journal-title":"J Nephrol"},{"key":"525_CR21","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1093\/ndt\/12.12.2735","volume":"12","author":"TA Chowdhury","year":"1997","unstructured":"Chowdhury TA, Lasker SS. Coexisting renal artery stenosis and primary aldosteronism. Nephrol Dial Transpl. 1997;12:2735\u20136.","journal-title":"Nephrol Dial Transpl."},{"key":"525_CR22","first-page":"800","volume":"77","author":"M Stowasser","year":"1993","unstructured":"Stowasser M, Gordon RD, Klemm SA, Tunny TJ. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis. J Clin Endocrinol Metab. 1993;77:800\u20134.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1210\/jc.2008-2245","volume":"94","author":"LA Sechi","year":"2009","unstructured":"Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab. 2009;94:1191\u20137.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/HYPERTENSIONAHA.115.05924","volume":"67","author":"Y Iwakura","year":"2016","unstructured":"Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, et al. Renal resistive index predicts postoperative blood pressure outcome in primary aldosteronism. Hypertension. 2016;67:654\u201360.","journal-title":"Hypertension."},{"key":"525_CR25","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","volume":"29","author":"VC Wu","year":"2011","unstructured":"Wu VC, Kuo CC, Wang SM, Liu KL, Huang KH, Lin YH, et al. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment. J Hypertens. 2011;29:1778\u201386.","journal-title":"J Hypertens."},{"key":"525_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.2214\/AJR.04.1445","volume":"186","author":"A Sigirci","year":"2006","unstructured":"Sigirci A, Hallac T, Akyncy A, Temel I, Gulcan H, Aslan M, et al. Renal interlobar artery parameters with duplex Doppler sonography and correlations with age, plasma renin, and aldosterone levels in healthy children. AJR Am J Roentgenol. 2006;186:828\u201332.","journal-title":"AJR Am J Roentgenol."},{"key":"525_CR27","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jcem.85.9.6819","volume":"85","author":"W Oelkers","year":"2000","unstructured":"Oelkers W, Diederich S, Bahr V. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage. J Clin Endocrinol Metab. 2000;85:3266\u201370.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20150469","volume":"130","author":"M Volpe","year":"2016","unstructured":"Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci. 2016;130:57\u201377.","journal-title":"Clin Sci."},{"key":"525_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ahj.2008.02.021","volume":"156","author":"JH Rutten","year":"2008","unstructured":"Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, et al. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome. Am Heart J. 2008;156:71\u20137.","journal-title":"Am Heart J."},{"key":"525_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.amjhyper.2004.09.016","volume":"18","author":"J Kato","year":"2005","unstructured":"Kato J, Etoh T, Kitamura K, Eto T. Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism. Am J Hypertens. 2005;18:354\u20137.","journal-title":"Am J Hypertens."},{"key":"525_CR31","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/1741826710389406","volume":"18","author":"W Lieb","year":"2011","unstructured":"Lieb W, Pencina MJ, Jacques PF, Wang TJ, Larson MG, Levy D, et al. Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community. Eur J Cardiovasc Prev Rehabil. 2011;18:664\u201373.","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"525_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.111.00791","volume":"62","author":"CL Asferg","year":"2013","unstructured":"Asferg CL, Nielsen SJ, Andersen UB, Linneberg A, Moller DV, Hedley PL, et al. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension. 2013;62:147\u201353.","journal-title":"Hypertension."},{"key":"525_CR33","doi-asserted-by":"publisher","first-page":"E340","DOI":"10.1210\/jc.2010-1355","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab. 2011;96:E340\u20136.","journal-title":"J Clin Endocrinol Metab."},{"key":"525_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/00004872-199816060-00017","volume":"16","author":"AH Danser","year":"1998","unstructured":"Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998;16:853\u201362.","journal-title":"J Hypertens."},{"key":"525_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000201791","volume":"32","author":"E Diamanti-Kandarakis","year":"2009","unstructured":"Diamanti-Kandarakis E, Economou FN, Livadas S, Tantalaki E, Piperi C, Papavassiliou AG, et al. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy. Kidney Blood Press Res. 2009;32:24\u201331.","journal-title":"Kidney Blood Press Res."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00525-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00525-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00525-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T11:05:57Z","timestamp":1650539157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00525-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1038\/s41371-021-00525-4","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}